← Leaderboards
Kevin E Yarasheski
Washington University
$10,842,858
Attributed
$10,842,858
Total exposure
50
Grants
31
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$10,842,858 · 50
By mechanism
R01$7,073,117 · 3
P41$1,542,305 · 30
R21$1,018,534 · 2
M01$577,581 · 13
R56$500,000 · 1
P60$131,321 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Michael J. Welch$5,631,366
- Gustav Schonfeld$4,592,788
- Carolyn J Anderson$12,609,741
- Robert J Gropler$22,166,148
- Douglas John Rowland$1,802,857
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectHiv InfectionsResearch PersonnelResourcesAids TherapyUnited States National Institutes Of HealthExerciseBiomedical ResourceMuscle MetabolismSourceDrug Adverse EffectGrantFundingInstitutionProtease InhibitorPathogenesisMuscleAdipose TissueMetabolismComputer Retrieval Of Information On Scientific Projects DatabaseHuman Therapy EvaluationInsulin ResistanceRate
Grant awards (95)
Collaboration and Service$95,962
P41 · FY2019 · GM · contact PI
Collaboration and Service$95,960
P41 · FY2018 · GM · contact PI
Collaboration and Service$95,960
P41 · FY2017 · GM · contact PI
Collaboration and Service$95,962
P41 · FY2016 · GM · contact PI
Collaboration and Service$95,962
P41 · FY2015 · GM · contact PI
MYOCARDIAL INSULIN RESISTANCE IS NOT WORSENED BY WELL-CONTROLLED HIV INFECTION$40,748
P41 · FY2011 · RR · contact PI
YOGA LIFESTYLE INTERVENTION REDUCES BLOOD PRESSURE IN HIV-INFECTED ADULTS$14,669
P41 · FY2011 · RR · contact PI
EXERCISE AND PIOGLITAZONE FOR HIV CARDIOMETABOLIC SYNDROMES$500,000
R56 · FY2009 · DK · contact PI
Myocardial Function and FFA Metabolism in HIV Metabolic Syndrome$515,225
R01 · FY2008 · DK · contact PI
Exercise & Pioglitazone for HIV-Metabolic Syndromes$308,441
R01 · FY2008 · DK · contact PI
ISOTOPE RATIO MASS SPECT IN HUMAN BIOLOGY AMINO ACID METABOLISM & KINETICS$8,880
P41 · FY2008 · RR · contact PI
CHARACTERIZING THE AGING MUSCLE MITOCHONDRIAL PROTEOME$8,031
P41 · FY2008 · RR · contact PI
EXERCISE AND PIOGLITAZONE FOR HIV-METABOLIC SYNDROMES$6,132
P41 · FY2008 · RR · contact PI
CHARACTERIZING THE HIV MUSCLE MITOCHONDRIAL PROTEOME$6,132
P41 · FY2008 · RR · contact PI
Myocardial Function and FFA Metabolism in HIV Metabolic Syndrome$510,422
R01 · FY2007 · DK · contact PI
Exercise & Pioglitazone for HIV-Metabolic Syndromes$314,736
R01 · FY2007 · DK · contact PI
Yoga for the Management of HIV-Metabolic Syndromes$112,053
R21 · FY2007 · AT · contact PI
EXERCISE AND PIOGLITAZONE FOR HIV METABOLIC SYNDROMES$93,014
M01 · FY2007 · RR · contact PI
YOGA FOR THE MANAGEMENT OF HIV-METABOLIC SYNDROMES$29,683
M01 · FY2007 · RR · contact PI
MYOCARDIAL FUNCTION AND FFA METABOLISM IN HIV-METABOLIC SYNDROME$20,779
M01 · FY2007 · RR · contact PI
REDUCING PLASMA HIV RNA IMPROVES MUSCLE AMINO ACID METABOLISM$14,418
P41 · FY2007 · RR · contact PI
EXERCISE AND PIOGLITAZONE FOR HIV-METABOLIC SYNDROMES$14,418
P41 · FY2007 · RR · contact PI
CHARACTERIZING THE HIV MUSCLE MITOCHONDRIAL PROTEOME$14,418
P41 · FY2007 · RR · contact PI
REDUCING PLASMA HIV RNA IMPROVES MUSCLE AMINO ACID METABOLISM$11,368
P41 · FY2007 · RR · contact PI
ISOTOPE RATIO MASS SPECT IN HUMAN BIOLOGY AMINO ACID METABOLISM & KINETICS$9,377
P41 · FY2007 · RR · contact PI
HUMAN AMYLOID - SYNTHESIS AND CLEARANCE RATES AS MEASURED IN CEREBROSPINAL FLUID$8,812
P41 · FY2007 · RR · contact PI
CHARACTERIZING THE AGING MUSCLE MITOCHONDRIAL PROTEOME$8,473
P41 · FY2007 · RR · contact PI
OLDER MEN ARE AS RESPONSIVE AS YOUNG MEN TO THE ANABOLIC EFFECTS$4,632
P41 · FY2007 · RR · contact PI
Myocardial Function /FFA Metabolism in HIV Metabolic Syn$511,742
R01 · FY2006 · DK · contact PI
Exercise & Pioglitazone for HIV-Metabolic Syndromes$324,136
R01 · FY2006 · DK · contact PI
Yoga for the Management of HIV-Metabolic Syndromes$224,107
R21 · FY2006 · AT · contact PI
Characterizing the HIV-Muscle Mitochondrial Proteme$223,374
R21 · FY2006 · DK · contact PI
EXERCISE AND PIOGLITAZONE FOR HIV METABOLIC SYNDROMES$98,717
M01 · FY2006 · RR · contact PI
LIPID KINETICS DURING ACUTE EXERCISE IN HIV$54,135
M01 · FY2006 · RR · contact PI
YOGA FOR THE MANAGEMENT OF HIV-METABOLIC SYNDROMES$22,291
M01 · FY2006 · RR · contact PI
REDUCING PLASMA HIV RNA IMPROVES MUSCLE AMINO ACID METABOLISM$13,924
P41 · FY2006 · RR · contact PI
EXERCISE AND PIOGLITAZONE FOR HIV-METABOLIC SYNDROMES$13,924
P41 · FY2006 · RR · contact PI
CHARACTERIZING THE HIV MUSCLE MITOCHONDRIAL PROTEOME$13,924
P41 · FY2006 · RR · contact PI
ISOTOPE RATIO MASS SPECT IN HUMAN BIOLOGY AMINO ACID METABOLISM & KINETICS$9,406
P41 · FY2006 · RR · contact PI
CHARACTERIZING THE AGING MUSCLE MITOCHONDRIAL PROTEOME$8,495
P41 · FY2006 · RR · contact PI
Myocardial Function /FFA Metabolism in HIV Metabolic Syn$510,450
R01 · FY2005 · DK
Exercise &Pioglitazone for HIV-Metabolic Syndromes$331,936
R01 · FY2005 · DK
Yoga for the Management of HIV-Metabolic Syndromes$267,750
R21 · FY2005 · AT
Characterizing the HIV-Muscle Mitochondrial Proteome$191,250
R21 · FY2005 · DK
LIPID KINETICS DURING ACUTE EXERCISE IN HIV$129,494
M01 · FY2005 · RR
ROSIGLITAZONE &EXERCISE TRAINING: EFFECTS ON HIV-INFECTED PEOPLE$36,476
M01 · FY2005 · RR
INSULIN RESISTANCE &CELL INSENSITIVITY ARE CHAR OF HIV GLUCOSE INTOLERANCE$33,856
P41 · FY2005 · RR
SWITCHING PROTEASE INHIBITOR COMBO ANTIRETROVIRAL THERAPY TO NEVIRAPINE FOR HIV$27,087
P41 · FY2005 · RR
VISCERAL ADIPOSITY, C-PEPTIDE LEVELS, AND LOW LIPASE ACTIVITIES PREDICT HIV-DYS$27,087
P41 · FY2005 · RR
MUSCLE LIPID METABOLISM IN HAART$11,854
M01 · FY2005 · RR
MANAGING SARCOPENIA W/ PROGRESSIVE RESISTANCE EXERCISE TRAINING$8,091
P41 · FY2005 · RR
ISOTOPE RATIO MASS SPECT IN HUMAN BIOLOGY AMINO ACID METABOLISM &KINETICS$8,091
P41 · FY2005 · RR
SERUM MYOSTATIN PROTEIN INCREASE IN 60-92 YEAR OLD WOMEN &MEN W/ MUSCLE WASTIN$6,475
P41 · FY2005 · RR
EXERCISE AND PIOGLITAZONE FOR HIV METABOLIC SYNDROMES$2,738
M01 · FY2005 · RR
MUSCLE LIPID METABOLISM IN HAART$342,626
R01 · FY2004 · DK
Muscle Lipid Metabolism in HAART$78,400
M01 · FY2004 · RR
INSULIN RESISTANCE &CELL INSENSITIVITY ARE CHAR OF HIV GLUCOSE INTOLERANCE$19,980
P41 · FY2004 · RR
HEPARIN RELEASABLE LIPOPROTEIN LIPASE ACTIVITY IS REDUCED IN HAART: HIV$15,987
P41 · FY2004 · RR
MANAGING SARCOPENIA W/ PROGRESSIVE RESISTANCE EXERCISE TRAINING$10,159
P41 · FY2004 · RR
ISOTOPE RATIO MASS SPECT IN HUMAN BIOLOGY AMINO ACID METABOLISM &KINETICS$10,159
P41 · FY2004 · RR
SOY ISOFLAVONES, EXERCISE, &BONE DENSITY IN OLDER MEN$8,128
P41 · FY2004 · RR
SERUM MYOSTATIN PROTEIN INCREASE IN 60-92 YEAR OLD WOMEN &MEN W/ MUSCLE WASTING$8,128
P41 · FY2004 · RR
MUSCLE LIPID METABOLISM IN HAART$342,738
R01 · FY2003 · DK
MUSCLE AMINO ACID METABOLISM IN AIDS CACHEXIA$371,212
R01 · FY2002 · DK
MUSCLE LIPID METABOLISM IN HAART$342,848
R01 · FY2002 · DK
MECHANISM(S) FOR METABOLIC COMPLICATIONS IN HIV$325,526
R01 · FY2002 · DK
ANNUAL SYMPOSIUM ON APPLICATION OF STABLE ISOTOPE TRACER METHODS$157,506
P41 · FY2002 · RR
ORAL GLUCOSE SUPPLEMENTATION ON PROTEIN METABOLISM FOLLOWING RESISTANCE TRAINING$157,506
P41 · FY2002 · RR
PROTEIN TURNOVER AND ANABOLIC INTERVENTION IN AIDS$0
M01 · FY2002 · RR
MUSCLE AMINO ACID METABOLISM IN AIDS CACHEXIA$0
M01 · FY2002 · RR
DIABETES AND LIPID DISORDERS IN HIV INFECTION TREATED WITH PROTEASE INHIBITORS$0
M01 · FY2002 · RR
DIABETES AND LIPID DISORDERS IN HIV INFECTED TREATED WITH PROTEASE INHIBITORS$0
M01 · FY2002 · RR
RESEARCH RESOURCES CORE D--METABOLIC FUNCTION AND BODY COMPOSITION$0
M01 · FY2002 · RR
MUSCLE AMINO ACID METABOLISM IN AIDS CACHEXIA$360,398
R01 · FY2001 · DK
MUSCLE LIPID METABOLISM IN HAART$342,954
R01 · FY2001 · DK
MECHANISM(S) FOR METABOLIC COMPLICATIONS IN HIV$316,372
R01 · FY2001 · DK
ORAL GLUCOSE SUPPLEMENTATION ON PROTEIN METABOLISM FOLLOWING RESISTANCE TRAINING$157,506
P41 · FY2001 · RR
ANNUAL SYMPOSIUM ON APPLICATION OF STABLE ISOTOPE TRACER METHODS$157,506
P41 · FY2001 · RR
PROTEIN TURNOVER AND ANABOLIC INTERVENTION IN AIDS$0
M01 · FY2001 · RR
RESEARCH RESOURCES CORE D--METABOLIC FUNCTION AND BODY COMPOSITION$0
M01 · FY2001 · RR
CORE--METABOLIC FUNCTION AND BODY COMPOSITION$0
P60 · FY2001 · AG
MUSCLE AMINO ACID METABOLISM IN AIDS CACHEXIA$0
M01 · FY2001 · RR
DIABETES AND LIPID DISORDERS IN HIV INFECTION TREATED WITH PROTEASE INHIBITORS$0
M01 · FY2001 · RR
DIABETES AND LIPID DISORDERS IN HIV INFECTED TREATED WITH PROTEASE INHIBITORS$0
M01 · FY2001 · RR
MUSCLE AMINO ACID METABOLISM IN AIDS CACHEXIA$349,903
R01 · FY2000 · DK
MUSCLE LIPID METABOLISM IN HAART$343,968
R01 · FY2000 · DK
MECHANISM(S) FOR METABOLIC COMPLICATIONS IN HIV$307,484
R01 · FY2000 · DK
CORE--METABOLIC FUNCTION AND BODY COMPOSITION$131,321
P60 · FY2000 · AG
ANNUAL SYMPOSIUM ON APPLICATION OF STABLE ISOTOPE TRACER METHODS$13,038
P41 · FY2000 · RR
ORAL GLUCOSE SUPPLEMENTATION ON PROTEIN METABOLISM FOLLOWING RESISTANCE TRAINING$6,028
P41 · FY2000 · RR
RESEARCH RESOURCES CORE D--METABOLIC FUNCTION AND BODY COMPOSITION$0
M01 · FY2000 · RR
MUSCLE AMINO ACID METABOLISM IN AIDS CACHEXIA$0
M01 · FY2000 · RR
DIABETES AND LIPID DISORDERS IN HIV INFECTION TREATED WITH PROTEASE INHIBITORS$0
M01 · FY2000 · RR
DIABETES AND LIPID DISORDERS IN HIV INFECTED TREATED WITH PROTEASE INHIBITORS$0
M01 · FY2000 · RR
PROTEIN TURNOVER AND ANABOLIC INTERVENTION IN AIDS$0
M01 · FY2000 · RR